Revolutionizing hepatocyte count for researchers

FHS
April 3, 2024
8:37 am

In this interview, NewsMedical speaks to DeNovix’s Dan Schieffer about the new app developed for CellDrop, and how it aims to revolutionize hepatocyte count for the drug discovery industry, and more.

Study finds long-COVID symptoms fluctuate over time, challenging treatment approaches

Study reveals that over half of long Covid patients experience fluctuating symptom severities over time, highlighting the dynamic nature of the condition. The research underscores

December 1, 2023

Lawsuit raises antitrust and kickback allegations around cancer patient referrals

A large independent group of oncologists in Philadelphia is suing the area’s dominant hospital system, Jefferson Health, alleging the system is violating federal antitrust and

September 9, 2023

Merck is on the lookout for more opportunities within immunology – Pharmaceutical Technology

Share this article Where Roche and Sanofi focused on acquiring their respective TL1A assets, MSD received additional tools and a biomarker library, which could allow

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.